Tornado Alley (PROG)

[fuagf]

Zardiw, dropdeadfred, Ivermectin: why a potential COVID treatment isn’t recommended for use

[...]

A controversy subsequently blew up over an article by the Front Line COVID-19 Critical Care Alliance .. https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf , a group of doctors and researchers that lobbies for the use of ivermectin.

This article, summarising multiple small studies of the effects of ivermectin on COVID-19 patients, was provisionally accepted for publication in the journal Frontiers in Pharmacology in January 2021 but then rejected and removed from the journal’s website in March .. https://www.the-scientist.com/news-opinion/frontiers-removes-controversial-ivermectin-paper-pre-publication-68505 . The journal’s editor stated that the standard of evidence in the paper was insufficient and that the authors were inappropriately promoting their own ivermectin-based treatment.

One larger randomised clinical trial was published in March 2021. This showed no effect of ivermectin on duration of symptoms of adults with mild COVID-19 .. https://jamanetwork.com/journals/jama/fullarticle/2777389 . The authors stated that the findings did not support the use of ivermectin in these patients, but again highlighted that larger trials were needed to determine whether the drug had other benefits.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164486962

-

Three in one here - Bar association serves legal notice to WHO chief scientist over Ivermectin guidelines
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165672232

This alone should shut you up on ivermectin

February 4, 2021 11:45 am ET

KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:

* No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies;

* No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and;

* A concerning lack of safety data in the majority of studies.

We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/

In giving you this one there is some duplication, but that's to combat the fact that
you obviously are happy to spread misinformation regarding ivermectin and covid

Homebrew, The medical world overwhelmingly says there is no high quality data to date which would justify CDC approval of ivermectin as a treatment for Covid. The studies most relied on so far by those pushing for approval have all been under the microscope, as all good scientific research is, and each for various reasons have come up wanting. Undeclared conflicts of interest evidence, unreliable data and suggestions of plagiarism included.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165681315